Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...
| Glavni autori: | , , , , |
|---|---|
| Format: | Članak |
| Jezik: | Russian |
| Izdano: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| Serija: | Российский кардиологический журнал |
| Teme: | |
| Online pristup: | https://russjcardiol.elpub.ru/jour/article/view/2326 |